(UCB) UCB - Performance 30.3% in 12m
Compare UCB with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
49.53%
#19 in Group
Rel. Strength
82.33%
#1411 in Universe
Total Return 12m
30.25%
#28 in Group
Total Return 5y
105.43%
#21 in Group
P/E 27.3
74th Percentile in Group
P/E Forward 19.9
64th Percentile in Group
PEG 2.52
80th Percentile in Group
FCF Yield 1.90%
53th Percentile in Group
12m Total Return: UCB (30.3%) vs XLV (1.7%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
-37.1% | 208% | 466% | 57.7 | 43.5 | 0.61 | 55.9% | 3.42% |
LLY NYSE Eli Lilly |
8.84% | 15.8% | 523% | 75.7 | 38.9 | 1.41 | 41.1% | 48.6% |
NVS NYSE Novartis |
1.8% | 21.1% | 74.9% | 19.2 | 13.7 | 1.3 | 35.8% | 4.22% |
SFZN SW Siegfried Holding |
8.63% | 12.1% | 131% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
NOVN SW Novartis |
-4.14% | 9.09% | 50% | 19.2 | 13.5 | 1.29 | 35.8% | 3.8% |
SOBI ST Swedish Orphan Biovitrum |
1.95% | 2.66% | 56.9% | 24.7 | 20.6 | 1.59 | 7.30% | 30.4% |
SAN PA Sanofi |
-5.91% | 7.31% | 26.6% | 18.5 | 11.2 | 0.9 | -20.4% | 16.2% |
SUPN NASDAQ Supernus Pharmaceuticals |
-0.82% | 7.91% | 46.7% | 24.4 | 20.2 | 1.47 | -13.6% | -12.5% |
Performance Comparison: UCB vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for UCB
Total Return (including Dividends) | UCB | XLV | S&P 500 |
---|---|---|---|
1 Month | -0.32% | -3.79% | -0.87% |
3 Months | -13.80% | -3.99% | -7.58% |
12 Months | 30.25% | 1.72% | 11.88% |
5 Years | 105.43% | 55.40% | 110.33% |
Trend Score (consistency of price movement) | UCB | XLV | S&P 500 |
1 Month | -17.0% | -3.2% | 23% |
3 Months | -85.7% | -71.4% | -88.5% |
12 Months | 64.2% | -17.5% | 55.1% |
5 Years | 34.3% | 89.8% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #93 | 3.61% | 0.55% |
3 Month | #105 | -10.2% | -6.74% |
12 Month | #29 | 28.1% | 16.4% |
5 Years | #21 | 32.2% | -2.33% |
FAQs
Does UCB UCB outperforms the market?
Yes,
over the last 12 months UCB made 30.25%, while its related Sector, the Health Care Sector SPDR (XLV) made 1.72%.
Over the last 3 months UCB made -13.80%, while XLV made -3.99%.
Over the last 3 months UCB made -13.80%, while XLV made -3.99%.
Performance Comparison UCB vs Indeces and Sectors
UCB vs. Indices UCB is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 6.97% | 0.55% | -6.39% | 18.4% |
US NASDAQ 100 | QQQ | 5.94% | -1.72% | -6.82% | 17.6% |
US Dow Jones Industrial 30 | DIA | 7.91% | 2.86% | -6.30% | 21.1% |
German DAX 40 | DAX | 8.20% | -1.64% | -25.9% | 5.57% |
Shanghai Shenzhen CSI 300 | CSI 300 | 10.9% | 2.50% | -3.40% | 24.3% |
Hongkong Hang Seng | HSI | 7.96% | -0.38% | -8.31% | 16.4% |
India NIFTY 50 | INDA | 9.81% | -4.38% | -6.68% | 27.2% |
Brasil Bovespa | EWZ | 7.77% | -4.92% | -10.1% | 36.1% |
UCB vs. Sectors UCB is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 6.72% | 0.73% | -12.5% | 6.29% |
Consumer Discretionary | XLY | 6.89% | -0.22% | -8.90% | 16.9% |
Consumer Staples | XLP | 10.5% | -0.52% | -11.7% | 19.1% |
Energy | XLE | 11.5% | 13.5% | -0.60% | 41.3% |
Financial | XLF | 8.36% | 1.79% | -14.0% | 7.56% |
Health Care | XLV | 7.05% | 3.47% | -4.70% | 28.5% |
Industrial | XLI | 6.55% | -0.43% | -7.10% | 20.7% |
Materials | XLB | 7.58% | 2.11% | 1.02% | 33.8% |
Real Estate | XLRE | 8.49% | 0.99% | -5.50% | 12.2% |
Technology | XLK | 4.52% | -2.01% | -3.05% | 22.5% |
Utilities | XLU | 9.81% | -0.38% | -8.51% | 8.42% |
Aerospace & Defense | XAR | 6.02% | -6.71% | -19.9% | 3.68% |
Biotech | XBI | 5.67% | -2.60% | 6.25% | 32.1% |
Homebuilder | XHB | 7.66% | 1.95% | 8.42% | 37.3% |
Retail | XRT | 8.54% | 0.24% | -0.82% | 33.0% |